Dexrazoxane (Cardioxane) as cardio - protector from anthracycline cardiotoxicity in high risk cancer patients / Hosam Darwish Abo Gad Alla ; Supervised Mostafa Mahmoud Elserafi , Nasr Mohamed Ali Allahloby , Mohamed Sayed Ahmed

By:

Hosam Darwish Abo Gad Alla

Contributor(s):

Language: Eng Publication details: Cairo : Hosam Darwish Abo Gad Alla , 2004Description: 168P : diagrs ; 25cmOther title:

استخدام عقار ديكسرازوكسان (كارديوكسان) للوقاية من اعتلال القلب الناتج عن استخدام الانثراسيكلين فى مرضى السرطان المعرضين للاصابة [Added title page title]

Subject(s):

Online resources:

Click here to access online

Available additional physical forms:

Issued also as CD

Dissertation note: Thesis (PH.D.) - Cairo University - National Cancer Institute - Department Of Oncology Summary: Anthracycline especially DOX are highly effective anti - neoplastic agent , so they widely used in treatment of large variety of malignant tumourThe most serious side effect of anthracycline is cardiotoxicity , the risk of cumulative toxic cardiomyopathy has an effect on the total dose of these drugs and reduce their therapeutic potential

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Call number	Status	Barcode
Thesis	قاعة الرسائل الجامعية - الدور الاول	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.19.04.Ph.D.2004.Ho.D. (Browse shelf(Opens below))	Not for loan	01010110043381000
CD - Rom	مخـــزن الرســائل الجـــامعية - البدروم	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.19.04.Ph.D.2004.Ho.D. (Browse shelf(Opens below))	Not for loan	01020110043381000

Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	Cai01.19.04.Ph.D.2004.Ha.R Role of high Dose cytarabine in remission induction of acute non lymphocytic leukemia : phase II prospective randomized trial /	Cai01.19.04.Ph.D.2004.Ha.R Role of high Dose cytarabine in remission induction of acute non lymphocytic leukemia : phase II prospective randomized trial /	Cai01.19.04.Ph.D.2004.Ho.D. Dexrazoxane (Cardioxane) as cardio - protector from anthracycline cardiotoxicity in high risk cancer patients /	Cai01.19.04.Ph.D.2004.Ho.D. Dexrazoxane (Cardioxane) as cardio - protector from anthracycline cardiotoxicity in high risk cancer patients /	Cai01.19.04.Ph.D.2004.Me.A Assessment of HER - 2 / neu oncogene amplification , ploidy and proliferative activity in node - negative breast carcinoma in relation to other histopathological parameters /	Cai01.19.04.Ph.D.2004.Me.A Assessment of HER - 2 / neu oncogene amplification , ploidy and proliferative activity in node - negative breast carcinoma in relation to other histopathological parameters /	Cai01.19.04.Ph.D.2004.Mo.C A comparative study for the management of low risk febrile neutropenic pediatric oncology patients at the national cancer institute (NCI) - Egypt /	Next

Thesis (PH.D.) - Cairo University - National Cancer Institute - Department Of Oncology

Anthracycline especially DOX are highly effective anti - neoplastic agent , so they widely used in treatment of large variety of malignant tumourThe most serious side effect of anthracycline is cardiotoxicity , the risk of cumulative toxic cardiomyopathy has an effect on the total dose of these drugs and reduce their therapeutic potential

Issued also as CD

There are no comments on this title.

to post a comment.

Click on an image to view it in the image viewer